Abstract
In the developed world, human toxoplasmosis is considered a benign self-limiting disease mostly detectable by specific antibody Toxoplasma gondii-immunoglobulin (Tg-Ig) testing. Patent and sometimes devastating disease may be appreciated in immune-compromised hosts and congenitally infected infants [1]. Congenital toxoplasmosis (CT) occurs almost exclusively when primary maternal infection occurs during gestation. As more than half of mothers giving birth to infected offspring could not recall an infection-related illness and no test reliably marks off infection time, there is pressure for screening. Alternative strategies include prenatal surveillance in Tg-Ig negative pregnant women and prophylaxis of fetal infection/damage in seroconverters, and newborn Tg-IgM testing on filter paper blood spots and sequelae prophylaxis in the Tg-IgM positive infant. Monthly or quarterly re-testing of unprotected pregnant women has been widely practised in the EU since the ’70s, whereas newborn testing has been included in the New England Neonatal Screening Program (NENSP) since 1986, and feasibility confirmed across the globe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965–1976
Gilbert R (2009) Treatment for congenital toxoplasmosis: finding out what works. Mem Inst Oswaldo Cruz 104: 305–311
Vaillant V, de Valk H, Baron E et al (2005) Foodborne infections in France. Foodborne Pathog Dis 2: 221–232
Bosch-Driessen LEH, Berendschot TTJM, Ongkosuwito JV, Rothova A (2002) Ocular toxoplasmosis. Clinical features and prognosis of 154 patients. Ophthalm 109: 869–878
Flegr J, Klose J, Novotná M et al (2009) Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect Dis 26; 9: 72
Zhu S (2009) Psychosis may be associated with toxoplasmosis. Med Hypotheses 73: 799–801
Carme B, Demar M, Ajzenberg D, Dardé ML (2009) Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 15: 656–658
Saeij JPJ, Boyle JP, Coller S et al (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780–1783
Jamieson SE, de Roubaix LA, Kuan Tan H et al (2008) COL2A1 and ABCA4 are epigenetically modified and associated with congenital toxoplasmosis. PLoS One 3: e2285
Kortbeek LM, Hofhuis A, Nijhuis CDM, Havelaar AH (2009) Congenital toxoplasmosis and DALYs in the Netherlands. Mem Inst Oswaldo Cruz 104: 370–373
Elbez-Rubinstein A, Ajzenberg D, Dardé ML et al (2009) Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 199: 280–285
Silveira C, Ferreira R, Muccioli C et al (2003) Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 136: 370–371
Systematic Review on Congenital Toxoplasmosis Study Group (SYROCOT), Thiébaut R, Leproust S et al (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 369: 115–122
McLeod R, Kieffer F, Sautter M et al (2009) Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz 104: 320–344
Roberts A, Hedman K, Luyasu V et al (2001) Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 20: 467–474
Gilbert RE, Thalib L, Tan HK et al (2007) Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 14: 8–13
Bessières MH, Berrebi A, Cassaing S et al (2009) Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz104: 389–392
Rilling V, Dietz K, Krczal D et al (2003) Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 22: 174–180
Kaiser K, Van Loon AM, Pelloux H et al (2007) Multicenter proficiency study for detection of Toxoplasma gondii in amniotic fluid by nucleic acid amplification methods. Clin Chim Acta 375: 99–103
Blankenberg FG, Nyu-Nyu Loh, Bracci P et al (2000) Sonography, CT, and MR imaging: a prospective comparison of neonates with suspected intracranial ischemia and hemorrhage. AJNR 21: 213–218
Hintz SR, Slovis T, Bulas D et al (2007). Interobserver reliability and accuracy of cranial ultrasound scanning interpretation in premature infants. J Pediatr 150: 592–596
Knoblauch H, Tennstedt C, Brueck W et al (2003) Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). Am J Med Genet 120A: 261–265
McLeod R, Boyer K, Karrison T et al (2006) Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42: 1383–1394
Phan L, Kasza K, Jalbrzikowski J et al (2008) Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol 146: 375–384
Phan L, Kasza K, Jalbrzikowski J et al (2008) Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmol 115: 553–559
Freeman K, Salt A, Prusa A et al (2005) Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children. BMC Pediatr 5: 23
Freeman K, Tan HK, Prusa A et al (2008) Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics 121: e1215–e1222
Gilbert RE, Freeman K, Lago EG et al (2008) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2: e277
Stramba-Badiale M, Nador F, Porta N et al (1997) QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates. Am Heart J 133: 108–111
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Buffolano, W. (2012). Toxoplasmosis in the Fetus and Newborn. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Milano. https://doi.org/10.1007/978-88-470-1405-3_115
Download citation
DOI: https://doi.org/10.1007/978-88-470-1405-3_115
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1404-6
Online ISBN: 978-88-470-1405-3
eBook Packages: MedicineMedicine (R0)